About the IVR

IVR Steering Group, Taskforce, and Core Team

IVR development was led by the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, with financial support from the Wellcome Trust. A steering group and a global taskforce of subject matter experts provided a wide range of knowledge and experience in influenza vaccines R&D. The taskforce was expanded following IVR development for the IVR monitoring, implementation, and adjustment (ME&A) phase; concurrently, some taskforce members retired from the project following IVR development. Current and former steering group, taskforce, and core team members are listed below:

Current Steering Group, Taskforce, and Core Team

Steering group

  • Joseph Bresee, MD, Task Force for Global Health, USA
  • Martin Friede, PhD, World Health Organization, Switzerland
  • Bruce Gellin, MD, MPH, Georgetown University School of Medicine, USA
  • Usman Nakakana, MBBS, MSc Vaccinology, Bill & Melinda Gates Foundation
  • Sonja Olsen, PhD, US Centers for Disease Control & Prevention, USA
  • Michael Osterholm, PhD, MPH, University of Minnesota, USA
  • Diane Post, PhD, National Institute of Allergy and Infectious Diseases (NIAID), USA
  • Sophia Wang, PhD, Wellcome, UK
  • Charlie Weller, PhD, Wellcome, UK

Taskforce

  • William Ampofo, PhD, University of Ghana, Ghana
  • Ed Belongia, MD, Marshfield Clinic Research Institute, USA
  • David Brown, MBBS, Oswaldo Cruz Foundation (FIOCRUZ), Brazil
  • Marco Cavaleri, PhD, European Medicines Agency, The Netherlands
  • Christopher Chadwick, PhD, MS, US Centers for Disease Control and Prevention, USA (formerly participated with the IVR Initiative as a steering group member)
  • Cheryl Cohen, PhD, University of the Witwatersrand, South Africa
  • Benjamin Cowling, PhD, University of Hong Kong, Hong Kong SAR, China
  • Rebecca Cox, PhD, University of Bergen, Norway
  • Jennifer Gordon, PhD, NIAID, USA
  • Swati Gupta, PhD, MPH, International AIDS Vaccine Institute, USA
  • Ian Gust, AO, MD, University of Melbourne, Australia
  • Scott Hensley, PhD, University of Pennsylvania, USA
  • Bruce Innis, MD, PATH Center for Vaccine Innovation & Access, USA
  • Irina Isakova-Sivak, PhD, Institute of Experimental Medicine, Russia
  • Kari Johansen, MD, PhD, European Centre for Disease Prevention and Control (retired), Sweden
  • Eric Karikari-Boateng, MPharm, Food and Drugs Authority, Ghana
  • Stacey Knobler, MPH, MSc, Science & Public Health Policy Expert, USA (formerly participated with the IVR Initiative as a steering group member)
  • Florian Krammer, PhD, Icahn School of Medicine at Mount Sinai, USA
  • John CW Lim, MBBS, MS, Duke-National University of Singapore Medical School, Singapore
  • John McCauley, PhD, Frances Crick Institute, UK
  • Richard Pebody, MBChB, PhD, UK Health Security Agency, UK
  • Punnee Pitisuttithum, MD, Mahidol University, Thailand
  • Rino Rappuoli, PhD, National Institute for Pandemic Preparedness, Italy
  • Tiago Rocca, Instituto Butantan, Brazil
  • Stacey Schultz-Cherry, PhD, St Jude Children’s Research Hospital, USA
  • Ethan Settembre, PhD, Seqirus, USA
  • Yue-Long Shu, PhD, China Center for Disease Control and Prevention, China
  • James Southern, PhD, Adviser to South African Health Products Regulatory Authority, South Africa
  • Kanta Subbarao, MBBS, Laval University, Canada; Doherty Institute, Australia
  • John S. Tam, PhD, Hong Kong Polytechnic University, Hong Kong SAR, China
  • Rajeev Venkayya, MD, Aerium Therapeutics, USA
  • Jerry Weir, PhD, Food and Drug Administration, USA

CIDRAP Core Team

  • Meredith Arpey, MPH, Research Assistant
  • Lauren Bigalke, MPH, Research Associate
  • Eve Lackritz, MD, Deputy Director and IVR Project Director
  • Anje Mehr, MPH, Research Specialist and IVR Project Manager
  • Kristine Moore, MD, MPH, Sr Advisory for Public Health Science & Policy, IVR Project Director until Apr 2023
  • Julie Ostrowsky, MSc, Research Scientist
  • Angela Ulrich, PhD, MPH, Assistant Professor and IVR Research Scientist
  • Natalie Vestin, MPH, Research Associate
  • Jim Wappes, Editorial Director

 

Former Steering Group, Taskforce, and Core Team

Former steering group

  • Francesco Berlanda Scorza, PhD, Bill & Melinda Gates Foundation, USA
  • Josie Golding, PhD, Wellcome, UK 
  • Peter Hart, PhD, Wellcome, UK
  • Rosalind Hollingsworth, PhD, Bill & Melinda Gates Foundation, USA
  • Keith Klugman, MD, PhD, Bill & Melinda Gates Foundation, USA
  • Ann Moen, MPA, US Centers for Disease Control & Prevention, USA
  • Divya Shah, PhD, Wellcome, UK
  • Padmini Srikantiah, MD, MPH, Bill & Melinda Gates Foundation, USA
  • Janet White, MBA, Bill & Melinda Gates Foundation, USA

Former Taskforce

  • Wendy Barclay, PhD, Imperial College London, UK
  • Amanda Glassman, MSc, Center for Global Development, USA
  • Gagandeep (Cherry) Kang, MBBS, MD, PhD, Christian Medical College, India
  • Jacqueline Katz, PhD, US Centers for Disease Control & Prevention (retired), USA
  • Yoshihiro Kawaoka, DVM, PhD, University of Wisconsin–Madison, USA
  • Janet McElhaney, MD; In memoriam, Dr. Janet E. McElhaney, 1954-2021; Scientific Director, Health Sciences North Research Institute, Sudbury, Ontario, Canada
  • Meta Roestenberg, MD, PhD, Leiden University, The Netherlands
  • Larisa Rudenko, MD, PhD, DSc, Institute of Experimental Medicine, Russia
  • Marilda Siqueira, PhD, Oswaldo Cruz Foundation (FIOCRUZ), Brazil

Former CIDRAP Core Team

  • Alison Kraigsley, PhD
  • Maya Peters, MPH